Michael Gibson, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Dr. Michael Gibson is a medical oncologist from Cleveland, Ohio and he works at several hospitals in the area, such as University Hospitals Cleveland Medical Center.He did his Medical Schooling from Johns Hopkins University School of Medicine and Residency in Internal Medicine from Johns Hopkins University. The doctor is certified in Medical Oncology from American Board of Internal Medicine and has an experience of more than 20 years.
Johns Hopkins University School of Medicine
Medical School
Johns Hopkins University
Residency
Johns Hopkins University
Fellowship
American Board of Internal Medicine - Oncology
PA State Medical License Active through 2014
OH State Medical License Active through 2019
Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC, Rezaee RP, Wang T, Garcia-Jarchow AM, Zender CA, Gibson M, Yao M, Lavertu P; Am J Otolaryngol. 2017-01-01.
See more >>Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.
Geiger JL, Bauman JE, Gibson MK, Gooding WE, Varadarajan P, Kotsakis A, Martin D, Gutkind JS, Hedberg ML, Grandis JR, Argiris A; Head Neck. 2016-12-01.
See more >>Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstett...; J Natl Compr Canc Netw. 2016-10-01.
See more >>